Strides Pharma Science's Stock Sees -5.71% Decline, Rated 'Hold' by MarketsMOJO

Strides Pharma Science, a midcap pharmaceutical company, has seen a decline in its stock price by -5.71% on November 25th, 2024. According to MarketsMOJO, the stock is currently rated as 'Hold' and has been a part of their Momentumnow Stocks since April 3rd, 2024.

The stock has underperformed the sector by -6.47% and has been on a consecutive fall for the past two days, with a -6.23% decrease in returns during this period. On November 25th, the stock touched an intraday low of Rs 1424.25, which is a -5.62% decrease from its previous closing price.

Despite the recent decline, Strides Pharma Science's moving averages are still higher than its 5 day, 100 day, and 200 day moving averages. However, it is currently lower than its 20 day and 50 day moving averages.

In comparison to the overall market performance, Strides Pharma Science's stock has shown a -6.39% decrease in the past day, while the Sensex has seen a 1.28% increase. Over the past month, the stock has also underperformed the Sensex with a -6.30% decrease in its performance.

As a midcap company in the pharmaceutical industry, Strides Pharma Science's stock performance is closely watched by investors. With the recent decline in its stock price, it will be interesting to see how the company's performance unfolds in the coming days.